Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Pulmonary/Respiratory Diseases | Trauma (Emergency, Injury, Surgery) | Immunology | Family Medicine
Disease Category: COPD (Chronic Obstructive Pulmonary Disease)
Location: United States, KY
This study evaluates the long-term safety of Roflumilast in patients with chronic COPD. The medication is already available and on the market today.
$100 per visit for visits 1-8 and $50 for visit 9 and $15 for unscheduled visits. You may be reimbursed up to $25
Males and Females over the age 40 with a diagnosis of moderate or severe COPD. Other criteria may apply.
Kentucky Medical Research
354 Waller Avenue, Suite 110
Lexington, KY 40504
Research Center Information: Kentucky Medical Research
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these